Annual Report 2016 ELIXIR Annual Report 2016
Total Page:16
File Type:pdf, Size:1020Kb
ELIXIR Annual Report 2016 Report Annual ELIXIR Annual Report 2016 ELXIR Annual Report 2016 1 Contents 2 Foreword by Torsten Schwede, Chair of ELIXIR Board (2015–2016) 3 Foreword by ELIXIR Director 5 ELIXIR Platforms and Use Cases 6 Structure of ELIXIR activities 8 Tools: Services and connectors to drive access and exploitation 10 Data: Sustaining Europe’s life science data infrastructure 11 Compute: Access, exchange and storage 12 Interoperability: Integration of data and services 14 Training: Professional skills for managing and exploiting data 16 Human data: Use case 17 Rare diseases: Use case 18 Marine metagenomics: Use case 19 Plant sciences: Use case 20 Platfrom and Use case leaders 23 ELIXIR members 24 Introducing ELIXIR UK 25 Introducing ELIXIR Germany 26 ELIXIR Nodes updates 32 2016 highlights 35 EU projects 36 ELIXIR-EXCELERATE 39 Collaboration with other Research Infrastructures 41 Supporting activities 42 Capacity building and Node development 43 Governance 44 Industry engagement 46 International collaboration 47 ELIXIR Working Groups 49 ELIXIR Hub activities 50 ELIXIR Communications 52 ELIXIR Hub staff 53 Governance Committees and financial data 54 ELIXIR Committees 57 Financial data 60 Commissioned Services: ELIXIR Implementation studies Foreword by Torsten Schwede I have watched ELIXIR develop since its conception and have been delighted to see its continued growth, year on year, since the Preparatory Phase. Yet 2016 was in many ways transformative for ELIXIR. The number of activities taking place in ELIXIR Nodes and across ELIXIR Platforms and Use Cases simply exploded. Four new Implementation Studies were initiated, five ELIXIR Node applications were approved and three Collaboration Agreements concluded. ELIXIR’s first ELSI (Ethical, Legal and Societal Issues) policy was developed in 2016, and the work to define indicators for ELIXIR Core Data Resources concluded. ELIXIR became the largest ESFRI research infrastructure in terms of membership, with 20 members in 2016. This rapid expansion of activities and membership is a clear indication of ELIXIR’s success, and shows the increasingly widespread recognition of bioinformatics as a driving force in the life sciences. 2016 also marked the maturity of ELIXIR: the European Strategy Forum on Research Infrastructures (ESFRI) recognised ELIXIR as a ‘landmark’ infrastructure in its 2016 Roadmap. I have had the privilege of sitting on the ELIXIR Board since its formation in 2014, serving the past two years as Chair. ELIXIR has achieved a great deal during that time, and I am looking forward to seeing it build and develop further. To realise the potential of computational biology to address the most pressing challenges we face, we must continue to develop ELIXIR at pace so that it may support new and emerging communities. Looking at the energy and commitment of our members, I continue to be enthusiastic about the achievements we can make together in 2017 and beyond. Torsten Schwede Chair of ELIXIR Board, 2015–2016 2 ELXIR Annual Report 2016 Foreword by ELIXIR Director The year 2016 marked the midway point in ELIXIR’s first Scientific Programme (2014– 2018), and was indeed transformational. Our two flagship projects, ELIXIR- EXCELERATE and CORBEL, were in full swing, allowing us to concentrate fully on infrastructure delivery and integration. This Annual Report highlights major achievements that illustrate the growth and maturity of our research infrastructure, which represents the combined efforts of 20 members. Integrated services Our goal is to establish a coordinated, integrated infrastructure for life-science data, and in 2016 we took major steps towards achieving just that. Our work on ELIXIR Core Data Resources was strategically important. These resources are essential to the wider life- science community, and to the long-term preservation of biological data. The ELIXIR Data Platform defined criteria for identifying Core Data Resources as well as the process by which they will be selected in 2017. These Core Data Resources will drive ELIXIR’s sustainability strategy, and serve as a basis for policy-level discussions. We launched the ELIXIR Authorisation and Authentication Infrastructure (AAI), a critical component of the ELIXIR Compute Platform for both users and service providers. AAI facilitates seamless access to ELIXIR services for researchers, and it gives ELIXIR service providers better control and management of access rights. Our Intranet was among the first services to use the ELIXIR AAI, so our partners can now share information more easily with one another from over 180 institutes. Other services that integrated the ELIXIR AAI were ELIXIR Beacons, discovery services that make human genomic datasets and cohorts discoverable and accessible by the global biomedical research community. The Beacons, developed in collaboration with the Global Alliance for Genomics and Health, define a global standard in data discovery. By the end of 2016, ELIXIR Beacons facilitated access to genomics data from six ELIXIR Nodes. In 2016 our members will engage more deeply in the Beacons project, new Nodes will participate and the ELIXIR-GA4GH collaboration will be expanded. ELXIR Annual Report 2016 3 Expanding membership Five new members joined ELIXIR in 2016: Italy, Slovenia, Ireland, Luxembourg and Germany. With these additions, we became the largest ESFRI Research Infrastructure in terms of membership. In the three years since our December 2013 launch, our membership has surged from the six founding members to 20. Looking ahead The second half of our current Scientific Programme focuses on expanding our efforts to accelerate the exploitation of open biological data. In 2017 we will further consolidate the ELIXIR's portfolio of services and initiate discussions about the next programming period (2019–2023). There are over 600 people actively contributing to ELIXIR, and each one has played a part in its success. We owe a lot to those whose hard work and dedication contributed to the development of ELIXIR in 2016: the ELIXIR Heads of Node, Technical and Training Coordinators, Platform and Use Case Leaders and everyone in ELIXIR Nodes. The achievements of 2016 have laid the foundations for accelerated progress in 2017 and beyond, and I look forward to continued success in this transformative era in the life sciences. Niklas Blomberg ELIXIR Director 4 ELXIR Annual Report 2016 ELIXIR Platforms and Use Cases Structure of ELIXIR activities ELIXIR activities are structured according ELIXIR Platforms are built on the real and changing to five Platforms and four Use Cases. needs of established research communities. The four Use Cases drive the work of the ELIXIR Platforms by defining These form the basic units of operation their bioinformatics needs and requirements. This close within ELIXIR, and draw on expertise and collaboration ensures that the services developed by the resources from ELIXIR Nodes. ELIXIR Platforms are fit for purpose. Senior scientists at the ELIXIR Nodes lead each of the The ELIXIR Platforms comprise: Platforms and Use Cases, which are primarily funded by • Data: Sustaining Europe’s life-science the ELIXIR-EXCELERATE project, in which each Platform data infrastructure and Use Case is represented by a Work Package. Additional activities are funded through other grants and through the • Tools: Services and connectors to drive access ELIXIR Hub as Implementation Studies. and exploitation • Interoperability: Supporting the discovery, integration and analysis of biological data • Compute: Storage, compute and authentication/ access services • Training: Professional skills for managing and exploiting data The four Use Cases service domain-specific research communities: • Human data: Developing long-term strategies for managing and accessing sensitive human data • Rare diseases: Supporting the development of new therapies for rare diseases • Marine metagenomics: Developing a sustainable metagenomics infrastructure to nurture research and innovation in marine science • Plant science: Developing an infrastructure to facilitate genotype-phenotype analyses for crop and tree species 6 ELXIR Annual Report 2016 Human data Rare diseases USE CASES Tools Data Compute PLATFORMS Inter- operability Training Marine Plant science metagenomics ELXIR Annual Report 2016 7 Tools Services and connectors for access and exploitation The Tools Platform is working to deliver Benchmarking a discovery portal that collects and curates Bioinformatics methods must be assessed for quantitative computational tools and data services performance and user friendliness to ensure they are fit for purpose. Benchmarking is thus a basic element of the for the life sciences. It is also developing ELIXIR infrastructure. These methods are so diverse in a framework for benchmarking and their design and purpose that it is necessary to abstract the evaluating bioinformatics tools from a scientific benchmark and technical monitoring processes in order to design an effective approach. This is an important scientific and technical perspective. part of the ELIXIR Tools Platform work programme, which is developing guidance and infrastructure for Bio.tools: ELIXIR tools and services registry benchmarking and monitoring bioinformatics tools, web In 2016 the Tools Platform focused on developing content, servers and algorithms. the underlying ontology (EDAM), portal software, In 2016, the Tools Platform mapped the needs of relevant sustainability strategy and applications for the bio.tools stakeholders and selected